HOME > 의약학 > 기타(의약학) > 대한흉부외과학회 > 대한흉부외과학회지
Extracorporeal Life Support in Adult Patients with Hematologic Malignancies and Acute Circulatory and/or Respiratory Failure -
분야 의약학 > 기타(의약학)
저자 Sungbin Cho Won Chul Cho Ju Yong Lim Pil Je Kang
발행기관 대한흉부외과학회
간행물정보 대한흉부외과학회지 2019년, The Korean Journal of Thoracic and Cardiovascular Surgery Vol.52 No.1, 25page~31page(총7page)
파일형식 3673368 [다운로드 무료 PDF 뷰어]
판매가격 6,000원
적립금 180원 (구매자료 3% 적립)
이 자료를
논문의 미리보기 2페이지를 PDF파일로 제공합니다.
연관 논문
ORIGINAL ARTICLE : Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies
The Korean Academy of Tuberculosis and Respiratory Diseases : Slide Session ; OS-096 : Critical Care ; Utility of High-Flow Nasal Cannula Oxygen Therapy for Acute Respiratory Failure in Patients with Hematologic Malignancies: A Retrospective Study in a Si
Free Paper Presentation : OS-96 ; Utility of High-Flow Nasal Cannula Oxygen Therapy for Acute Respiratory Failure in Patients with Hematologic Malignancies: A Retrospective Study in a Single Center
Acute Kidney Injury and Prognosis in Adult Respiratory FailureM Patients with Veno-venous Extracorporeal Membrane Oxygenation
S-360 ECMO as a rescue therapy for acute respiratory failure during chemotherapy in a patient with AML
부제 :
Background: The primary goal of this study was to characterize the clinical outcomes of adult patients with hematologic malignancies (HM) who were treated with extracorporeal membrane oxygenation (ECMO) support when conventional treatments failed. Methods: In this retrospective, observational study at a tertiary medical center, we reviewed the clinical course of 23 consecutive patients with HM requiring ECMO who were admitted to the intensive care unit at Asan Medical Center from March 2010 to April 2015. Results: A total of 23 patients (8 female; median age, 44 years; range, 29–51 years) with HM and severe acute circulatory and/or respiratory failure received ECMO therapy during the study period. Fourteen patients received veno-arterial ECMO, while 9 patients received veno-venous ECMO. The median ECMO duration was 104.7 hours (range, 37.1–221 hours). Nine patients were successfully weaned from ECMO. The in-hospital mortality rate was 91.1% (21 of 23). There were complications in 3 patients (cannulation site bleeding, limb ischemia, and gastrointestinal bleeding). Conclusion: ECMO is a useful treatment for patients with circulatory and/or pulmonary failure. However, in patients with HM, the outcomes of ECMO treatment results were very poor, so it is advisable to carefully decide whether to apply ECMO to these patients.
Mortality, Extracorporeal membrane oxygenation, Hematologic neoplasms, Adult
본 논문은 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
[PBL] 전신부종과 호흡곤란을 호소한 젊은 여자
[[솔루션]] :: Lehninger Biochemistry 5edition[the foundations of Biochemistry]
[PBL] 비장절제술(Splenectomy)의 방법
[자연] 두통에 대해서
headache 레포트
[영어]공무원 영어시험
[의료경영] 미국 대체의학 및 Post Acute-care
적혈구와 백혈구의 수 측정
[토익]영어단어 보카33000
[교양] 정보 인프라 관련 미국정부 논문
오늘 본 자료
오늘 본 자료가 없습니다.
장바구니 담은 자료
장바구니가 비어 있습니다.
이 간행물 인기자료
The Korean Journal of Thoracic and ...
Leriche’s 증후군에서 흉부하행대동...
관상동맥우회술 후 발생한 뇌혈관계 ...
Clinical Practice Guideline for Car...
Erratum: Staged Surgical Treatment ...
이 간행물 신규자료
Cardiopulmonary Bypass Strategies t...
Robotically Assisted Mitral Valve R...
Development of Castleman Disease in...
Thoracic Splenosis after Splenic an...
Chylous Manifestations and Manageme...
저작권 정보
본 학술논문은 ㈜누리미디어와 각 학회간에 저작권 계약이 체결된 것으로 HAPPY학술이 제공하고 있습니다. 본 저작물을 불법적으로 이용시는 법적인 제재가 가해질 수 있습니다.
서비스이용약관 | 개인정보취급방침 | E-mail 수집 거부 | 제휴 및 광고문의 | FAQ
이메일 무단 수집 거부
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 수집되는 것을 거부하며, 이를 위반시 정보통신망법에 의해 형사처벌됨을 유념하시기 바랍니다. [게시일 2003년 4월 2일]